Patricia Maiso

4.7k total citations · 1 hit paper
64 papers, 3.1k citations indexed

About

Patricia Maiso is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Patricia Maiso has authored 64 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hematology, 29 papers in Molecular Biology and 19 papers in Genetics. Recurrent topics in Patricia Maiso's work include Multiple Myeloma Research and Treatments (35 papers), Chronic Lymphocytic Leukemia Research (19 papers) and Chemokine receptors and signaling (9 papers). Patricia Maiso is often cited by papers focused on Multiple Myeloma Research and Treatments (35 papers), Chronic Lymphocytic Leukemia Research (19 papers) and Chemokine receptors and signaling (9 papers). Patricia Maiso collaborates with scholars based in United States, Spain and Italy. Patricia Maiso's co-authors include Aldo M. Roccaro, Antonio Sacco, Irene M. Ghobrial, Jesús F. San Miguel, Feda Azab, Abdel Kareem Azab, Enrique M. Ocio, Atanasio Pandiella, Ludmila M. Flores and Phong Quang and has published in prestigious journals such as Journal of Clinical Investigation, Blood and PLoS ONE.

In The Last Decade

Patricia Maiso

63 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression

2013 645 citations Aldo M. Roccaro, Antonio Sacco et al. profile →

Peers

Countries citing papers authored by Patricia Maiso

Since Specialization

Citations

This map shows the geographic impact of Patricia Maiso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Maiso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Maiso more than expected).

Fields of papers citing papers by Patricia Maiso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Maiso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Maiso. The network helps show where Patricia Maiso may publish in the future.

Co-authorship network of co-authors of Patricia Maiso

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Maiso. A scholar is included among the top collaborators of Patricia Maiso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Maiso. Patricia Maiso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma 2019 ·Clinical Cancer Research ·Laura Moreno, Cristina Pérez, Aintzane Zabaleta, Irene Manrique, Diego Alignani, Daniel Ajona, Laura Blanco, Marta Lasa, Patricia Maiso, Idoia Rodríguez, Sonia Gárate, Tomáš Jelı́nek, Víctor Segura, Cristina Moreno, Juana Merino, Paula Rodríguez‐Otero, Carlos Panizo, Felipe Prósper, Jesús F. San Miguel, Bruno Paiva	148
2	Pre-Clinical Efficacy of the Anti-CD38 Monoclonal Antibody (mAb) Isatuximab in Acute Myeloid Leukemia (AML) 2017 ·Blood ·Tomáš Jelı́nek, Aintzane Zabaleta, Cristina Pérez, Daniel Ajona, Diego Alignani, Idoia Rodríguez, Sonia Gárate, Sarai Sarvide, Marta Lasa, Patricia Maiso, Felipe Prósper, Roman Hájek, Jesús F. San Miguel, Bruno Paiva	3
3	Metabolic Signature Identifies Novel Targets for Drug Resistance in Multiple Myeloma 2015 ·Cancer Research ·Patricia Maiso, Daisy Huynh, Michele Moschetta, Antonio Sacco, Yosra Aljawai, Yuji Mishima, John M. Asara, Aldo M. Roccaro, Alec C. Kimmelman, Irene M. Ghobrial	166
4	microRNA Aberrations in Waldenström Macroglobulinemia 2013 ·Clinical Lymphoma Myeloma & Leukemia ·Antonio Sacco, Yong Zhang, Patricia Maiso, Salomon Manier, Giuseppe Rossi, Steven P. Treon, Irene M. Ghobrial, Aldo M. Roccaro	10
5	Novel Tumor Suppressor Function of Glucocorticoid-Induced TNF Receptor GITR in Multiple Myeloma 2013 ·PLoS ONE ·Yang Liu, Phong Quang, Esteban Braggio, Hai T. Ngo, Gayane Badalian‐Very, Ludmila M. Flores, Yong Zhang, Antonio Sacco, Patricia Maiso, Abdel Kareem Azab, Feda Azab, Ruben D. Carrasco, Barrett J. Rollins, Aldo M. Roccaro, Irene M. Ghobrial	12
6	Mirna Expression Profiling and Proteomic Analysis Of Circulating Exosomes From Multiple Myeloma Patients 2013 ·Blood ·Salomon Manier, (unknown), Siobhan Glavey, Antonio Sacco, Patricia Maiso, Yuji Mishima, (unknown), Ranjit Banwait, Wenjing Zhang, Yu Zhang, İlyas Şahin, Michele Moschetta, (unknown), (unknown), Michaela R. Reagan, John M. Asara, Xavier Leleu, Aldo M. Roccaro, Irene M. Ghobrial	1
7	Mechanisms of Activity of the TORC1 Inhibitor Everolimus in Waldenstrom Macroglobulinemia 2012 ·Clinical Cancer Research ·Aldo M. Roccaro, Antonio Sacco, Xiaojing Jia, Ranjit Banwait, Patricia Maiso, Feda Azab, Ludmila M. Flores, Salomon Manier, Abdel Kareem Azab, Irene M. Ghobrial	11
8	Carfilzomib-Dependent Selective Inhibition of the Chymotrypsin-like Activity of the Proteasome Leads to Antitumor Activity in Waldenstrom's Macroglobulinemia 2011 ·Clinical Cancer Research ·Antonio Sacco, Monette Aujay, (unknown), Abdel Kareem Azab, Patricia Maiso, Yang Liu, Yong Zhang, Feda Azab, Hai T. Ngo, Ghayas C. Issa, Phong Quang, Aldo M. Roccaro, Irene M. Ghobrial	34
9	Hypoxia Promotes Dissemination of Multiple Myeloma Through Acquisition of Endothelial to Mesenchymal Transition (EMT) Features 2011 ·Blood ·Abdel Kareem Azab, Jinsong Hu, Phong Quang, Feda Azab, Costas Pitsillides, Brian Thompson, Patricia Maiso, Aldo M. Roccaro, Antonio Sacco, Hai T. Ngo, Ghayas C. Issa, Charles Lin, Andrew L. Kung, Karin Vanderkerken, Irene M. Ghobrial	1
10	Targeting the Bone Marrow in Waldenstrom Macroglobulinemia 2011 ·Clinical Lymphoma Myeloma & Leukemia ·Irene M. Ghobrial, Yong Zhang, Yang Liu, Hai T. Ngo, Feda Azab, Antonio Sacco, (unknown), Patricia Maiso, (unknown), Phong Quang, Ghayas C. Issa, Xavier Leleu, Aldo M. Roccaro	4
11	Transcriptomic rationale for the synergy observed with dasatinib + bortezomib + dexamethasone in multiple myeloma 2011 ·Annals of Hematology ·Edvan de Queiroz Crusoé, Patricia Maiso, Diego Fernández‐Lázaro, Laura San‐Segundo, Mercedes Garayoa, Antonio García-Gómez, Norma C. Gutiérrez, (unknown), Enrique Colado, Jesús Martín, Francis Y. Lee, Enrique M. Ocio	4
12	Role of TORC1 and TORC2 in Multiple Myeloma 2011 ·Blood ·Patricia Maiso, Yi Liu, Abdel Kareem Azab, (unknown), Feda Azab, Antonio Sacco, Michaela R. Reagan, Hai T. Ngo, Yang Liu, Yong Zhang, Charles P. Lin, Aldo M. Roccaro, Christian Rommel, Irene M. Ghobrial	1
13	The bone marrow microenvironment in Waldenstrom macroglobulinemia 2011 ·Therapeutic Advances in Hematology ·Irene M. Ghobrial, Patricia Maiso, (unknown), Yang Liu, Yong Zhang, Ghayas C. Issa, Feda Azab, Antonio Sacco, Phong Quang, Hai T. Ngo, Aldo M. Roccaro	5
14	Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biology 2010 ·Journal of Hematology & Oncology ·Antonio Sacco, Ghayas C. Issa, Yong Zhang, Yang Liu, Patricia Maiso, Irene M. Ghobrial, Aldo M. Roccaro	13
15	Selectin Inhibition Disrupts Multiple Myeloma Cells Interaction with the Bone Marrow Microenvironment and Sensitizes Them to Therapy 2010 ·Blood ·Abdel Kareem Azab, Phong Quang, Feda Azab, John L. Magnani, John T. Patton, Theodore A Smith, Arun K. Sarkar, Patricia Maiso, Hai T. Ngo, Aldo M. Roccaro, Antonio Sacco, Yang Liu, Yong Zhang, (unknown), Kenneth C. Anderson, Andrew L. Kung, Ruben D. Carrasco, Irene M. Ghobrial	1
16	The synergy of panobinostat plus doxorubicin in acute myeloid leukemia suggests a role for HDAC inhibitors in the control of DNA repair 2009 ·Leukemia ·Patricia Maiso, Enrique Colado, Enrique M. Ocio, Mercedes Garayoa, Jesús Martín, Peter Atadja, Atanasio Pandiella, Jesús F. San Miguel	57
17	New drugs in multiple myeloma: mechanisms of action and phase I/II clinical findings 2008 ·The Lancet Oncology ·Enrique M. Ocio, María‐Victoria Mateos, Patricia Maiso, Atanasio Pandiella, Jesús F. San Miguel	93
18	The insulin‐like growth factor‐I receptor inhibitor NVP‐AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cells 2008 ·British Journal of Haematology ·Patricia Maiso, Enrique M. Ocio, Mercedes Garayoa, Juan Carlos Montero, Francesco Hofmann, Carlos Garcı́a-Echeverrı́a, Johann Zimmermann, Atanasio Pandiella, Jesús F. San Miguel	31
19	Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals 2007 ·Leukemia ·Norma C. Gutiérrez, Enrique M. Ocio, Javier De Las Rivas, Patricia Maiso, María del Mar Delgado, Encarnación Fermiñán, María José Arcos, (unknown), Jesús María Hernández‐Rivas, Jesús F. San Miguel	147
20	The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype 2007 ·Haematologica ·Enrique Colado, Stela Álvarez-Fernández, Patricia Maiso, Jesús Martín, María‐Belén Vídriales, Mercedes Garayoa, Enrique M. Ocio, Juan Carlos Montero, Atanasio Pandiella, Jesús F. San Miguel	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact